The approval came relatively quickly by using the De Novo premarket review pathway, which streamlines the process for products with “low to moderate risk.” You may have to wait a while before you see OsteoDetect in use at the family doctor’s office. However, you might see considerably more AI going forward. FDA commissioner Scott Gottlieb …
Continue reading “FDA approves AI tool for spotting wrist fractures”